Metagenomic Sequencing Market Size, Share, Growth and Trends, Forecast 2024-2031

Global Metagenomic Sequencing Market reached USD 1.7 billion in 2023 and is expected to reach USD 6.8 billion by 2031 and is expected to grow with a CAGR of 19.3% during the forecast period 2024-2031.

Metagenomics is a field of research focused on the genomic analysis of microbial DNA extracted from environmental communities. This approach uses metagenomic sequencing techniques to analyze genes within a sample, allowing scientists to evaluate bacterial diversity and identify various microbes present in different environments. The key steps in metagenomic sequencing include DNA extraction, library preparation, sequencing, assembly, annotation, and statistical analysis.

The Metagenomic Sequencing market study provides a comprehensive analysis, offering both quantitative and qualitative insights. It includes a detailed outlook and forecast of the global market, segmented by product and service, workflow, and application. This analysis helps to understand the current trends and future potential of the metagenomic sequencing market.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/metagenomic-sequencing-market

Market Dynamics:

Advanced technological platforms and improved genomic tools, is expected to drive the global metagenomic sequencing market during the forecast period.

A key driver of the metagenomic sequencing market's growth is the ongoing development of faster sequencing techniques and advancements in handling the vast amounts of data generated. These improvements enhance researchers' ability to analyze microbial communities across diverse environments. The market is also bolstered by the increasing adoption of advanced bioinformatics tools, high throughput screening (HTS) methods, the discovery of novel drugs, and cost-effective technologies like next-generation sequencing (NGS).

Next-generation DNA sequencing (NGS) has revolutionized molecular biology research, offering applications that extend beyond traditional DNA sequencing methods. For instance, on May 28, 2019, Macrogen Inc., a precision medicine biotechnology company, received South Korean accreditation for Good Clinical Lab Practices from the Ministry of Food and Drug Safety (MFDS) and was designated as a clinical trial specimen analysis institution. This accreditation is expected to enhance Macrogen's clinical diagnostic metagenomics capabilities.
Overall, the continuous advancements in DNA sequencing technology are anticipated to drive significant growth in the metagenomic sequencing market over the forecast period.

Segment Covered in the Metagenomic Sequencing Market:

By Product & Service: Instruments, Reagents & Consumables, Analyses & Data Interpretation Solutions, Services, Others.

By Workflow: Data Processing & Analysis, Sample Processing & Library Preparation, Sequencing.

By Technology: Shotgun Metagenomic Sequencing, 16S rRNA Sequencing, Whole Genome Sequencing & De Novo Assembly, Metatranscriptomics.

By Application: Drug Discovery, Clinical Diagnostics, Veterinary Applications, Ecological and Environmental Applications, Industrial applications, Soil Microbiome Applications, Others.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/metagenomic-sequencing-market

Key players involved in Metagenomic Sequencing Market:

• Thermo Fisher Scientific Inc.
• Qiagen N.V.
• BGI Group
• DNAstar, Inc.
• Eurofins Scientific
• Illumina, Inc.
• Macrogen, Inc.
• Oxford Nanopore Technologies Ltd.
• NuGEN Technologies, Inc. (A Wholly Owned Subsidiary of Tecan Trading AG)
• F. Hoffmann-La Roche Ltd.
• Perkinelmer, Inc.
• Integragen SA
• Microsynth AG
• Novogene Co., Ltd.
• Zymo Research Corporation

Note:

• Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.

Regional Analysis:

The Metagenomic Sequencing Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Metagenomic Sequencing Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

Influenza Vaccines Market: https://www.datamintelligence.com/research-report/influenza-vaccines-market

Regenerative Medicine Market: https://www.datamintelligence.com/research-report/regenerative-medicine-market

Microfluidics Market: https://www.datamintelligence.com/research-report/microfluidics-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.